TransDigm adds Irina Krasik to board of directors

TransDigm Group Incorporated appointed Irina Krasik to its Board of Directors, effective July 22, 2026.

Rhea-AI Filing Summary

TransDigm Group Incorporated appointed Irina Krasik to its Board of Directors, effective July 22, 2026. She is a Managing Director at Stellex Capital Management and previously worked at Bregal Investments, The Wicks Group, The Carlyle Group and Merrill Lynch in investment roles.

She also serves on several private-company boards, bringing experience in mergers and acquisitions, investing, corporate strategy and governance. She has not yet been named to any board committees, there are no related person transactions with TransDigm, and she will be paid under the standard non-employee director compensation program described in the 2026 proxy statement.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Board appointment effective date: July 22, 2026 Common stock par value: $0.01 per share Commission File Number: 001-32833 +2 more

5 metrics

Board appointment effective date July 22, 2026 Date the Board appointed Irina Krasik as a director

Common stock par value $0.01 per share Par value of TransDigm’s common stock

Commission File Number 001-32833 SEC registration file number for TransDigm Group Incorporated

IRS Employer Identification No. 41-2101738 Federal tax identification number for TransDigm Group Incorporated

Company telephone number (216) 706-2960 Main telephone contact for TransDigm’s principal executive offices

Key Terms

Emerging Growth Company, related person transactions, Item 404(a) of Regulation S-K, non-employee directors, +1 more

5 terms

Emerging Growth Company regulatory

"...Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2). Emerging Growth Company..."

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

related person transactions regulatory

"There are no related person transactions between Ms. Krasik and the Company..."

Transactions between a company and individuals or entities that have close relationships to the company’s insiders or major owners, such as executives, directors, their family members, or firms they control. These deals matter to investors because they can affect the company's finances or fairness—like a shop owner buying supplies from a relative’s business, which could be normal but might also favor the relative or mask conflicts of interest—so transparency and terms are closely watched.

Item 404(a) of Regulation S-K regulatory

"...transactions between Ms. Krasik and the Company that would be reportable under Item 404(a) of Regulation S-K."

non-employee directors financial

"...standard compensation arrangements for non-employee directors as set forth in the Company’s proxy statement..."

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

proxy statement regulatory

"...as set forth in the Company’s proxy statement for its 2026 annual meeting."

A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did TransDigm Group (TDG) announce?

TransDigm Group appointed Irina Krasik to its Board of Directors, effective July 22, 2026. She joins as a non-employee director and will receive standard board compensation, adding experience in mergers and acquisitions, investing, corporate strategy and governance from prior private equity and investment roles.

What is Irina Krasik’s professional background relevant to TransDigm (TDG)?

Irina Krasik is a Managing Director at Stellex Capital Management, where she has worked since 2021. Her prior experience includes roles at Bregal Investments, The Wicks Group, The Carlyle Group and Merrill Lynch, focused on investing, mergers and acquisitions, and corporate strategy.

Does Irina Krasik sit on any board committees at TransDigm (TDG)?

No, Irina Krasik has not been appointed to any committees of TransDigm’s Board of Directors. She currently serves solely as a director, though the Board may later assign her to committees consistent with its governance practices and needs.

Are there related person transactions between Irina Krasik and TransDigm Group (TDG)?

There are no related person transactions between Irina Krasik and TransDigm that require disclosure. The company states there are no transactions reportable under Item 404(a) of Regulation S-K, indicating no disclosable financial relationships between her and the company.

How will Irina Krasik be compensated as a TransDigm (TDG) director?

Irina Krasik will receive board compensation under TransDigm’s standard arrangements for non-employee directors. These terms are described in the company’s proxy statement for its 2026 annual meeting, and she will be paid consistently with other outside directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/24/2026 - 07:15 AM EDT Learn about SEC filing dates

0001260221false00012602212026-07-222026-07-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 22, 2026

TransDigm Group Incorporated

(Exact name of registrant as specified in its charter)

Delaware

001-32833

41-2101738

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

1350 Euclid Avenue,

Suite 1600,

Cleveland,

Ohio

44115

(Address of principal executive offices)

(Zip Code)

(216) 706-2960

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:

Trading Symbol:

Name of each exchange on which registered:

Common Stock, $0.01 par value

TDG

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 22, 2026, the Board of Directors (the “Board”) of TransDigm Group Incorporated (the “Company” or “TransDigm”) appointed Irina Krasik to the Company’s Board of Directors, effective immediately.

Ms. Krasik has been with Stellex Capital Management since 2021 and serves as a Managing Director. Prior to joining Stellex Capital Management, she was a Principal at Bregal Investments and previously spent more than eight years at The Wicks Group in various investment roles. Earlier in her career, Ms. Krasik held positions at The Carlyle Group and Merrill Lynch. She currently serves on the boards of directors of several privately held companies and brings to the Board extensive experience in mergers and acquisitions, investing, corporate strategy and governance. Ms. Krasik holds an M.B.A. from Harvard Business School and a B.S. in Finance from Rutgers University.

Ms. Krasik has not been appointed to any committees of the Board.

There are no arrangements or understandings between Ms. Krasik and any other person pursuant to which she was selected as a director, and there are no related person transactions between Ms. Krasik and the Company that would be reportable under Item 404(a) of Regulation S-K. Ms. Krasik will receive compensation for her services on the Company’s Board of Directors in accordance with the Company’s standard compensation arrangements for non-employee directors as set forth in the Company’s proxy statement for its 2026 annual meeting.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TRANSDIGM GROUP INCORPORATED
By:									/s/ Armani Vadiee
			Name:						Armani Vadiee
			Title:						General Counsel, Chief Compliance Officer and Secretary

Dated: July 24, 2026

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 22.3 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.8 KB